Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2015 Sep 25;22(4):617–626. doi: 10.1016/j.bbmt.2015.09.015

Table 3.

Overview of studies on outcome after acute respiratory failure for children post-transplant requiring mechanical ventilation

Study design Enrollment period Ventilated HSCT patients (n) PICU survival (%) Long-term survival Factors associated with mortality Ref
Retrospective 1983-1996 121 16 N/A Respiratory failure
Pulmonary dysfunction
>1 organ dysfunction
97
Retrospective 1990-1999 86 41 20% 2 yr Hepatic dysfunction
Use of HFOV
98
Retrospective 1991-2000 34 24 N/A Male gender
MOF ≥ 3
Hemorrhagic cystitis
GVHD Gr III-IV
99
Prospective 1993-2001 24 21 17% 1 yr MOF 100
Retrospective 1994-1998 31 42 13% 6 mo MV > 48 hours 101
Retrospective 1998-2001 13 15 NR MV > 5 days 102
Retrospective 1992-2004 65 *59% 54% 100 d PaO2/FiO2 < 300
PEEP > 8 cm 24 hours
No survivor HFOV
103
Meta-analysis 1973-2004 822 29% N/A Pulmonary infection 104
Retrospective 1996-2004 206 45% 18% 6 mo Previous intubation
Within 6 months
Hepatic/cardiac failure
105
Retrospective 2000-2006 36 31% 25% 6 mo MV > 7 days
CRRT > 7 days
Pressor support
106
Retrospective 2002-2009 28 31% N/A **Oxygenation index ≥ 25 associated with 100% mortality 107
Retrospective 2004-2010 88 39% N/A CRRT 108

Abbreviations : PICU, pediatric intensive care-unit; N/A, not available; MOF, multi-organ failure; MV, mechanical ventilation; PEEP, positive-end expiratory pressure; CRRT, continuous renal replacement therapy; d, days; mo, months; yr, year.

*

During the period 2000-2004

**

Oxygenation index is defined as FiO2/PaO2 × mean airway pressure.